← Back to Provider List

AMERICAN DIALYSIS CENTERS, NORTH LAS VEGAS LLC SOS Verified

Clinic/Center, End-Stage Renal Disease (ESRD) Treatment · NORTH LAS VEGAS, NV

4107 W CHEYENNE AVE, NORTH LAS VEGAS, NV 89032

NPI Number
1023599784
Street View of 4107 W CHEYENNE AVE, NORTH LAS VEGAS, NV 89032

Practice location · View on Google Maps

SOS Verification: Verified
Entity Name: AMERICAN DIALYSIS CENTERS, NORTH LAS VEGAS LLC
Entity Number: E0401112017-1
Entity Type: Domestic Limited-Liability Company
Entity Status: Active
Formation Date: 2017-08-23
Name Match: 95%
Registered Agent
Name: Cyril Ovuworie
Type: Non-Commercial Registered Agent
Address: 4107 W Cheyenne Avenue, North Las Vegas, NV, 89032
Mailing: 900 S. Main Street, Las Vegas, NV
Officers / Principals
TitleNameAddressStatus
ManagerCYRIL OVUWORIE4107 W Cheyenne Avenue, North Las Vegas, NVActive
Total Medicaid Payments
$497,618
-86% vs specialty average
Patients Seen
192
Total Claims
2,594
$ Per Patient
$2,592
Specialty avg: $170
Specialty Rank
#46 of 52
Clinic/Center, End-Stage Renal Disease (ESRD) Treatment providers in Nevada
Peer Average
$3,517,617
Average total for Clinic/Center, End-Stage Renal Disease (ESRD) Treatment
Claims per Patient
13.5
Average visits / services per person

Payments by Year

How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.

Year Total Paid % of Max
2023$238,292
2024$259,326

Procedure Code Breakdown

The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.

HCPCS Code Description Claims Paid % of Total Avg per Claim
90999Dialysis or kidney treatment — other related procedure2,594$497,618
100.0%
$192

About This Data

This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.